Verve's Poppins receives favorable HAS reimbursement opinion
It marks the first early-reimbursement decision for a digital therapeutic in France, following nine years of clinical work.
See the latest news and media coverage for Verve. We track all announcements, press releases, and industry mentions in real time, all in one place.
European deep-tech venture capital investor
verve.vcLast updated
In short: Verve achieved a major regulatory milestone by securing a FINMA securities firm license and celebrated several high-value portfolio exits.
It marks the first early-reimbursement decision for a digital therapeutic in France, following nine years of clinical work.
The trial targets US approval for a point-of-care cardiac imaging system using ¹⁵O-water.
The license allows Verve to offer institutional-grade access to European tech investments under Swiss regulation.
The total potential consideration exceeds €700 million, advancing a first-in-class antibody for kidney transplant patients.
Financial services support specialist Verve has reported a record-breaking first quarter of 2026 for its human-led services.
Stockholm, 31 March 2026 – The Board of Directors of Verve Group SE (ISIN: SE0018538068) resolved to initiate a relocation of the Company’s legal...
Verve Group SE invites investors, analysts, and media to its Capital Markets Day 2026 in New York, showcasing its strong market presence in North America...
The fate of the Verve nightclub hangs in the air after the Vigo County Alcoholic Beverage Board has recommended its liquor license not be renewed...
Track Verve and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Verve and other trending companies.